In the microbial underworld, carbapenem-resistant Enterobacterales (CRE) are the mafia bosses. But three new enforcers—Meropenem-nacubactam, Meropenem-vaborbactam, and Meropenem-xeruborbactam—are storming the scene. Each has a unique fighting style, a signature move, and a target list of resistant bacteria. Let’s pit them against each other in a no-holds-barred showdown.

🧫 Imipenem-Funobactam vs Imipenem-Relebactam: A New Era in Combating Superbugs

You think you know Cat Scratch Disease (CSD)? Think again. It’s not just a benign lymphadenopathy after a playful swipe from a kitten. In the shadows of this zoonotic infection lies a spectrum of atypical presentations that can mimic everything from viral encephalitis to culture-negative endocarditis. And if you're prepping for FRCPath Part 2, this is the kind of curveball that separates the good from the great.

Imagine this: a patient with culture-negative endocarditis, fever of unknown origin, and a history of cat exposure. Blood cultures are blank. Serology hints at Bartonella henselae. You reach for doxycycline, azithromycin, maybe rifampin. But here’s the kicker—none of them will kill the bug. Welcome to the paradox of Bartonella treatment: only aminoglycosides are bactericidal. Everything else? Just bacteriostatic passengers.

In the labyrinth of hepatitis B diagnostics, most candidates focus on the usual suspects: HBsAg, anti-HBc, HBeAg, and HBV DNA. But lurking beneath the surface is a molecular oracle that reveals the virus’s true intentions—HBV core-related antigen (HBcrAg). For FRCPath Part 1 and 2 aspirants, understanding HBcrAg isn’t optional—it’s a high-yield secret weapon that bridges virology, immunology, and clinical decision-making.

In the world of HIV medicine, antiretroviral therapy (ART) is the cornerstone of viral suppression. But what if some individuals could naturally control HIV—without any drugs? Enter the Elite Controllers: a rare group of HIV-positive individuals who defy the rules of virology and immunology. For FRCPath Part 1 and 2 candidates, understanding this phenomenon isn’t just fascinating—it’s exam gold.

MALDI-TOF: The Microbial Messiah with Blind Spots — What FRCPath Aspirants Must Know!

BORSA: The Borderline Oxacillin-Resistant Staphylococcus aureus You Shouldn’t Ignore

Candida species are significant opportunistic fungal pathogens, particularly in immunocompromised patients. Among them, Candida parapsilosis has emerged as an important cause of invasive candidiasis, especially in hospital settings. Understanding its microbiology, clinical significance, diagnosis, and management is crucial for candidates preparing for the FRCPath Medical Microbiology exams.

🔥 Think meropenem is out once the lab calls it 'resistant'?Think again. In OXA-48-producing Klebsiella pneumoniae, carbapenems may still save lives—if you know when and how to use them.

What Microbiologists & Trainees Must Know in 2025 📍 Why This Topic Matters In the face of rising multidrug-resistant (MDR) Gram-negative...

🧪 Does a Positive Catheter Tip Culture Confirm CLABSI? Understanding the Difference Between CRBSI and CLABSI

🔬 Autoclave Sterilization: Residence Time vs Holding Time – What's the Difference and Why It Matters?

Cephalosporins in Staphylococcus aureus: EUCAST Guidance Explained 🔍

Limitations of VITEK and MALDI-TOF in Salmonella Identification — What FRCPath Part 2 Candidates Must Know